
Windtree Therapeutics Announces Reverse Stock Split to Maintain Nasdaq Compliance
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common stock. The company’s board approved the move following authorization granted by stockholders during …
Windtree Therapeutics Announces Reverse Stock Split to Maintain Nasdaq Compliance Read More